- Home
- AGEN vs CHR Comparison
AGEN vs CHR Comparison
Compare AGEN & CHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGEN | CHR |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.2M | 142.9M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGEN | CHR |
|---|---|---|
| Price | $3.38 | $0.83 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 486.5K | 60.2K |
| Earning Date | 03-16-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $42,877,086.00 | N/A |
| Revenue This Year | $61.42 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.89 | ★ $0.01 |
| Revenue Growth | ★ 89.95 | N/A |
| 52 Week Low | $1.38 | $0.03 |
| 52 Week High | $7.34 | $2.09 |
Technical Indicators
Market Signals| Indicator | AGEN | CHR |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 24.83 |
| Support Level | $2.91 | $0.07 |
| Resistance Level | $4.72 | $0.84 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 38.97 | 12.06 |
Price Performance
Historical ComparisonAbout AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.